NUTRA PHARMA CORP cotiza a 0.00 USD y tiene una capitalización bursátil de $715973. En los últimos 12 meses ha facturado $160815 con un margen de flujo de caja libre del -461.9%. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Nutra Pharma Corp., a biopharmaceutical company, acquires, licenses, and commercializes pharmaceutical products and technologies, and drugs for the management of pain, neurological disorders, cancer, and autoimmune and infectious diseases in the United States. The company offers Nyloxin/Nyloxin Extra Strength, an over-…
| Métrica | NPHC | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 76.3% | 57.0% | +19.3% |
| Operating Margin | -567.6% | -38.6% | -529.0% |
| Net Margin | -794.8% | -33.6% | -761.2% |
| FCF Margin | -461.9% | -13.9% | -448.1% |
| ROE | — | -40.4% | — |
| ROA | -350.3% | -32.0% | -318.2% |
| Current Ratio | 0.03 | 2.84 | -2.81 |
| Debt / Equity | -0.58 | 0.28 | -0.86 |